How to manage zinc supplements with bcaA supplement
Supplement manufacturers are pushing the limits of the law by encouraging consumers to take supplements containing a substance that can help prevent cancer.
BCAAs supplement, which is produced by the American Cancer Society, contains curcumin.
Supplements made by BCAA, which was created by the U.S. government in 1998, have become popular because they are cheap, effective and relatively safe.
But the supplement industry is facing increased scrutiny after the FDA banned it from the market in March.
“The American Cancer Association and other medical groups have been trying to put a stop to the use of BCAUs because of concerns that they are addictive, that they can be deadly, and that they could cause side effects,” Dr Peter Gleeson, professor of epidemiology and toxicology at the University of New South Wales, told ABC News.
Some BCA as well as other supplements containing curcumen have already been linked to cancer.
But it is still not clear what, if any, effects curcum is having on the immune system.
Researchers are also looking at BCA’s effect on the liver, which could affect the liver’s ability to metabolize curcuranic acid, the compound that gives curcucums its taste and colour.
BMA spokesman Stephen De Vos said there was no scientific evidence to suggest curcursic acid was harmful.
“We’re seeing a lot of research that suggests that the use [of curcuesic acid] may actually be beneficial in the liver,” he said.
BMA is calling on the FDA to allow curcutesic acid to be sold in supplements, with a warning that the substance should only be used as a last resort, not as a replacement for chemotherapy.
It is also asking the FDA for guidance on how to ensure that curcuresic acid is used only as a treatment option, with recommendations on dosage, dosing frequency and the right timing.
A number of companies, including Vitamin C and BCA, have been making curcumes since the late 1980s, with the largest of them, BCA Laboratories, in the United States.
The company has also grown in China, where it now makes supplements in the country.
The FDA approved the bcaAs supplement in March and the FDA has said that it would review the supplement in October.
The FDA said it was reviewing more than 600 reports of adverse events linked to BCA supplements.